LRA Researchers Star at ACR/ARP – Part 2
Last week we gave you only half the story of what scientists funded by the Lupus Research Alliance (LRA)...
Stories & News
Breadth of Clinical Research Presented at the 2019 ACR/ARP Annual Meeting Brings Hope for New Lupus Treatments
November 14, 2019
The Lupus Research Alliance staff was on the ground at the 2019 ACR/ARP Annual Meeting and highly...
The Lupus Research Alliance Partners with the National Kidney Foundation to Offer Course to Healthcare Professionals
November 12, 2019
The Lupus Research Alliance (LRA) is pleased to announce a new collaboration with the National Kidney Foundation...
LRA-Funded Scientists Command Attention at 2019 ACR/ARP
November 14, 2019
The Lupus Research Alliance was proud of the unprecedented number of the studies supported by the Alliance...
Two Lupus Therapeutics Studies Report Positive Results at 2019 ACR/ARP Annual Meeting
November 12, 2019
Two positive clinical studies presented at the 2019 ACR/ARP Annual Meeting were conducted through the Lupus Clinical...
Potential Lupus Nephritis Treatment Works Well with Mycophenolate Acid
November 8, 2019
Aurinia Pharmaceuticals announced results from a study showing that their investigational drug voclosporin did not significantly impact...
Raising Thousands for Lupus Research; Running the NYC Marathon for Life Without Lupus
November 4, 2019
Big thanks go to our Team Life Without Lupus, who put their heart and soul into running...
New Studies Suggest AVISE Lupus Test Improves Diagnosis of Disease
October 28, 2019
Because lupus is hard to diagnose, many patients don’t get the treatments they need, while others get...
Potential New Treatment in Phase III Trial
The Lupus Research Alliance is excited to announce that a potential new medicine for lupus—anifrolumab—reduced disease activity versus placebo...
10 Lupus Therapeutics Studies Currently Underway
TAK-079
A Study to Evaluate the Safety of TAK-079
PAISLEY-SLE
A Phase II study to evaluate a novel, oral therapy in SLE
ORKIDS
A...
Welcoming Daniel J. Wallace, MD to Lupus Therapeutics
The Lupus Research Alliance (LRA) affiliate Lupus Therapeutics is pleased to announce that Daniel J. Wallace, MD joins as...
Peer-to-Peer Involvement Advances Scientific Exploration
Many dynamics of lupus contribute to the fact that its complexities have eluded the scientific community—but new hope may...